Posted: Mar 02, 2021 7:58 PM MT | Last Updated: March 3
Injectable opioid agonist therapy has been shown effective for many people suffering with severe opioid use disorder. (Shutterstock )
Alberta says it will continue to fund injectable opioid agonist treatment (iOAT) for current patients under a two-year grant.
It comes as the government faces a lawsuit brought by 11 patients who say Alberta s move to end funding for the life-saving program is a violation of their Charter rights.
Staff were told about the grant in a conference call on Tuesday morning, two AHS employees with knowledge of the iOAT program told CBC News.
CBC is not naming the two AHS employees because they were not authorized to speak publicly about the grant.